Columbia Sportswear Company Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments And Risk Management (Tables)

9 Months Ended

Sep. 30, 2015

The following table presents the gross notional amount of outstanding derivative instruments (in thousands):



	September 30, 2015		December 31, 2014		September 30, 2014
Derivative instruments designated as cash flow hedges:
Currency forward contracts	$	133,500	$	103,000	$	103,000
Derivative instruments not designated as cash flow hedges:
Currency forward contracts	81,000		128,000		62,837

The following table presents the balance sheet classification and fair value of derivative instruments (in thousands):



	Balance Sheet Classification	September 30, 2015		December 31, 2014		September 30, 2014
Derivative instruments designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	$	2,101	$	9,993	$	5,986
Currency forward contracts	Other non-current assets	309		—		—
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	170		—		—
Derivative instruments not designated as cash flow hedges:
Derivative instruments in asset positions:
Currency forward contracts	Prepaid expenses and other current assets	391		2,754		2,708
Derivative instruments in liability positions:
Currency forward contracts	Accrued liabilities	489		924		—

The following table presents the statement of operations effect and classification of derivative instruments (in thousands):



	Statement of Operations Classification	Three Months Ended September 30,						Nine Months Ended September 30,
	Statement of Operations Classification	2015			2014			2015			2014
Currency Forward and Option Contracts:
Derivative instruments designated as cash flow hedges:
Gain recognized in other comprehensive income or loss	—	$	789		$	5,404		$	5,629		$	5,474
Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion	Net sales	187			—			187			—
Gain reclassified from accumulated other comprehensive income or loss to income for the effective portion	Cost of sales	8,878			556			12,825			2,055
Loss recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Net sales	(3		)	(13		)	(20		)	(13		)
Gain (loss) recognized in income for amount excluded from effectiveness testing and for the ineffective portion	Cost of sales	84			(120		)	(126		)	(328		)
Derivative instruments not designated as cash flow hedges:
Gain recognized in income	Other non-operating income (expense)	260			5,368			2,840			3,397